Ex vivo engineering of the tumor microenvironment / Amir R. Aref, David Barbie, editors
Contributor(s): Aref, Amir R.,, editor literario | Barbie, David,, editor literario
Material type:
E-bookSeries: (Cancer drug discovery and development).Publisher: Cham : Humana Press, 2017Description: 1 recurso en línea.ISBN: 3319453955; 3319453971; 9783319453958; 9783319453972.Subject: Cáncer -- Aspectos genéticos
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC268.4 E985 2017 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.20022630 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RC268.4 .E653 2016 EB Epigenetics, Energy Balance, and Cancer | RC268.4 E654 2015 EB Epigenetics Territory and Cancer | RC268.4 .E654 2016 EB Epigenetic Advancements in Cancer | RC268.4 E985 2017 EB Ex vivo engineering of the tumor microenvironment | RC268.4 .G593 2016 EB Glycosignals in Cancer: Mechanisms of Malignant Phenotypes | RC268.4 .H57 2013 EB The Hippo Signaling Pathway and Cancer | RC268.4 .H634 2014 EB A Practical Guide to Human Cancer Genetics |
SpringerLink
Incluye referencias bibliográficas
1. Introduction to Ex Vivo Cancer Models -- 2. Patient-derived Xenografts in Oncology -- 3.Organoid Culture: Applications in Development and Cancer -- 4. Microfluidics and future of cancer diagnostics -- 5. Advancing techniques and insights in circulating tumor cell (CTC) research -- 6. The Cancer Secretome -- 7. An overview of the tumor microenvironments and future of cancer therapy.
This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time.
Online resource; title from PDF title page (EBSCO, viewed December 20, 2016).
There are no comments on this title.